Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Nalesnik

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Clinicopathologic characteristics of post-transplant lymphoproliferative disordersMichael A Nalesnik
Blood|February 23, 2013
Plasma cell tumors in transplant patientsMichael A Nalesnik
Current Opinion in Organ Transplantation|December 18, 2010
On the crossroad between tolerance and posttransplant lymphomaMichael A Nalesnik, Thomas E Starzl
World Journal of Gastroenterology|August 1, 2013
Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature reviewEizaburo Sasatomi, Michael A Nalesnik, J Wallis Marsh
The American Journal of Surgical Pathology|November 24, 2006
Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic studyLawrence R Johnson, Michael A Nalesnik, Steven H Swerdlow
Human Pathology|September 19, 2008
Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinomaMichael A Nalesnik, Michael Federle, David Buck, et al.
The American Surgeon|May 6, 2008
Unresectable hepatocellular carcinoma with a solitary metastasis to the mandibleRyan Li, Rohan R Walvekar, Michael A Nalesnik, et al.
Digestive Diseases and Sciences|February 14, 2008
Altered liver morphology after portal vein thrombosis: not always cirrhosisMitchell E Tublin, Alexander J Towbin, Michael P Federle, et al.
Transplantation|June 7, 2003
Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cellsAtsunori Nakao, Michael A Nalesnik, Takashi Ishikawa, et al.
American Journal of Physiology. Renal Physiology|April 17, 2009
Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft functionAtsunori Nakao, Gaetano Faleo, Michael A Nalesnik, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 12, 2002
Clinicopathologic characteristics of post-transplant lymphoproliferative disordersMichael A Nalesnik
Blood|February 23, 2013
Plasma cell tumors in transplant patientsMichael A Nalesnik
Current Opinion in Organ Transplantation|December 18, 2010
On the crossroad between tolerance and posttransplant lymphomaMichael A Nalesnik, Thomas E Starzl
World Journal of Gastroenterology|August 1, 2013
Neuroendocrine carcinoma of the extrahepatic bile duct: case report and literature reviewEizaburo Sasatomi, Michael A Nalesnik, J Wallis Marsh
The American Journal of Surgical Pathology|November 24, 2006
Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic studyLawrence R Johnson, Michael A Nalesnik, Steven H Swerdlow
Human Pathology|September 19, 2008
Hepatobiliary effects of 90yttrium microsphere therapy for unresectable hepatocellular carcinomaMichael A Nalesnik, Michael Federle, David Buck, et al.
The American Surgeon|May 6, 2008
Unresectable hepatocellular carcinoma with a solitary metastasis to the mandibleRyan Li, Rohan R Walvekar, Michael A Nalesnik, et al.
Digestive Diseases and Sciences|February 14, 2008
Altered liver morphology after portal vein thrombosis: not always cirrhosisMitchell E Tublin, Alexander J Towbin, Michael P Federle, et al.
Transplantation|June 7, 2003
Chimerism and tolerance in rat recipients of intestinal allografts from ALS-treated donors with and without adjunct naïve-donor-strain bone-marrow cellsAtsunori Nakao, Michael A Nalesnik, Takashi Ishikawa, et al.
American Journal of Physiology. Renal Physiology|April 17, 2009
Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft functionAtsunori Nakao, Gaetano Faleo, Michael A Nalesnik, et al.
Pageof 6